Immediate Impact
6 standout
Citing Papers
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
2023 Standout
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
2023 Standout
Works of Anders Frische being referenced
Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine
2022
In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anders Frische | 79 | 29 | 16 | 6 | 88 | |
| Huahua Wan | 83 | 28 | 28 | 7 | 111 | |
| Tochi Anioke | 65 | 13 | 10 | 6 | 71 | |
| Qing Xiong | 105 | 38 | 15 | 8 | 131 | |
| Anne P. Werner | 60 | 15 | 34 | 5 | 107 | |
| Ren Yang | 118 | 23 | 37 | 9 | 167 | |
| Jordi Chi | 91 | 13 | 26 | 5 | 124 | |
| Chantal Morrisseau | 112 | 11 | 13 | 4 | 117 | |
| Laurie Gokool | 112 | 11 | 13 | 4 | 117 | |
| Hao-Rui Si | 65 | 36 | 10 | 10 | 80 | |
| Gabriel Dagotto | 108 | 14 | 28 | 6 | 142 |
All Works
Login with ORCID to disown or claim papers
Loading papers...